DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
- 4 November 1998
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 13 (6) , 877-884
- https://doi.org/10.1002/mds.870130604
Abstract
DNA fragmentation was examined in situ in flashfrozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT‐mediated dUTP‐biotin 3′ end‐labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis‐like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.Keywords
This publication has 25 references indexed in Scilit:
- Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's diseaseMovement Disorders, 1998
- Apoptotic features of selective neuronal death in ischemia, epilepsy and gpI20 toxicityTrends in Neurosciences, 1996
- Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.Journal of Clinical Investigation, 1995
- Temporal Profile of in situ DNA Fragmentation after Transient Middle Cerebral Artery Occlusion in the RatJournal of Cerebral Blood Flow & Metabolism, 1995
- DNA damage consistent with apoptosis in transient focal ischaemic neocortexNeuroReport, 1994
- Rapid Communication: Regional Variability in DNA Fragmentation After Global Ischemia Evidenced by Combined Histological and Gel Electrophoresis Observations in the Rat BrainJournal of Neurochemistry, 1993
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissueJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985